The authorisation comes three months after the MHRA approved Johnson & Johnson’s Lazcluze (lazertinib), which is also ...

What does SAY’s healthcare communications crystal ball reveal for the coming year? We’ve looked at what we can expect to see ...

Otsuka Pharmaceutical has shared positive results from a late-stage study of its investigational monoclonal antibody ...

Mental health awareness has seen incredible change – in no small part down to communications teams in private and public ...

Artificial intelligence (AI) is rapidly transforming industries. Healthcare is no exception. The conversation around AI’s ...

Medscape Hematology will be at EHA 2025 to showcase the power of education impact through online abstracts, posters, and 4 ...